Cytovene

Cytovene is a brand name of ganciclovir, approved by the FDA in the following formulation(s):

CYTOVENE (ganciclovir sodium - injectable; injection)

• 
  Manufacturer: ROCHE PALO
  
  Approval date: June 23, 1989
  
  Strength(s): EQ 500MG BASE/VIAL ^[RLD][AP]

Has a generic version of Cytovene been approved?

Yes. The following products are equivalent to Cytovene:

GANCICLOVIR (ganciclovir sodium injectable; injection)

• 
  Manufacturer: APP PHARMS
  
  Approval date: June 21, 2010
  
  Strength(s): EQ 500MG BASE/VIAL ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cytovene. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Cytovene.

See also...

• Cytovene Consumer Information (Wolters Kluwer)
• Cytovene Capsules Consumer Information (Wolters Kluwer)
• Cytovene oral and injectable Consumer Information (Cerner Multum)
• Cytovene Advanced Consumer Information (Micromedex)
• Cytovene IV Advanced Consumer Information (Micromedex)
• Cytovene AHFS DI Monographs (ASHP)
• Ganciclovir Consumer Information (Wolters Kluwer)
• Ganciclovir Capsules Consumer Information (Wolters Kluwer)
• Ganciclovir oral and injectable Consumer Information (Cerner Multum)
• Ganciclovir Oral, Intravenous Advanced Consumer Information (Micromedex)
• Ganciclovir Sodium AHFS DI Monographs (ASHP)